Axon regeneration in the central nervous system is limited both by inhibitory extracellular cues and by an intrinsically low capacity for axon growth in some CNS populations. Chondroitin sulfate proteoglycans (CSPGs) are well-studied inhibitors of axon growth in the CNS, and degradation of CSPGs by chondroitinase has been shown to improve the extension of injured axons. Alternatively, axon growth can be improved by targeting the neuron-intrinsic growth capacity through forced expression of regeneration-associated transcription factors. For example, a transcriptionally active chimera of Krüppel-like Factor 7 (KLF7) and a VP16 domain improves axon growth when expressed in corticospinal tract neurons. Here we tested the hypothesis that combined expression of chondroitinase and VP16-KLF7 would lead to further improvements in axon growth after spinal injury. Chondroitinase was expressed by viral transduction of cells in the spinal cord, while VP16-KLF7 was virally expressed in sensory neurons of the dorsal root ganglia or corticospinal tract (CST) neurons. After transection of the dorsal columns, both chondroitinase and VP16-KLF7 increased the proximity of severed sensory axons to the injury site. Similarly, after complete crush injuries, VP16-KLF7 expression increased the approach of CST axons to the injury site. In neither paradigm however, did single or combined treatment with chondroitinase or VP16-KLF7 enable regenerative growth distal to the injury. These results substantiate a role for CSPG inhibition and low KLF7 activity in determining the net retraction of axons from sites of spinal injury, while suggesting that additional factors act to limit a full regenerative response.
Introduction
Recovery from injury to the central nervous system (CNS) is limited by the inability of severed axons to regenerate and re-establish effective communication. Axon regeneration is constrained in part by cell-intrinsic mechanisms in many axotomized CNS neurons, including a failure to initiate needed pro-regenerative transcriptional programs (Blackmore, 2012; Moore and Goldberg, 2011) . One well-studied example is the differential regenerative ability of the peripherally versus centrally projecting branches of sensory axons. Successful axon regeneration of the peripheral branch depends on the transcription of regeneration associated genes (RAGs) in the sensory cell body (Smith and Skene, 1997), which in turn depends on transcription factors that are themselves upregulated or activated in response to peripheral axotomy (Ben-Yaakov et al., 2012; Broude et al., 1997; Jankowski et al., 2009; Michaelevski et al., 2010; Tsujino et al., 2000) . In contrast, injury to the centrally projecting axon triggers RAG expression that is smaller in magnitude and shorter in duration (Broude et al., 1997; Geeven et al., 2011; Ma and Willis, 2015; Stam et al., 2007) . In the same way, many CNS neurons respond to axotomy with modest and/or transient RAG expression (Chaisuksunt et al., 2000) . This failure of RAG expression appears particularly acute in the case of corticospinal tract (CST) neurons after spinal axotomy (Mason et al., 2003) , and likely contributes to the relatively modest CST response to a wide range of attempted pro-regenerative therapies (Hollis et al., 2009; Lee et al., 2010b; Pearse et al., 2004; Richardson et al., 1984) .
These observations have led to the hypothesis that regeneration by central DRG axons and/or CNS axons might be improved by forced expression of RAGs, particularly key transcription factors that may orchestrate regenerative gene expression (Ma and Willis, 2015; van Kesteren et al., 2011) . For example, Krüppel-like factor 7 is a pro-regenerative transcription factor that is normally expressed in peripheral neurons and in CNS neurons during embryonic periods of axon growth, but downregulated in the adult CNS (Laub et al., 2001) . We have shown previously that forced expression of a transcriptionally active form, VP16-KLF7, improves axon growth in adult CST neurons after spinal injury (Blackmore et al., 2012) . The degree of axon regeneration remains incomplete, however, highlighting the need to identify and overcome additional mechanisms that limit CNS axon growth. 
